Database activity in Japan

Nosocomial SARS-CoV-2 Infections in Japan: A Cross-sectional Newspaper Database Survey

P03-023 – Autoinflammatory diseases database in Japan

Introduction In recent years, responsible genes for autoinflammatory diseases have been increasingly known and clinical phenotype-genotype correlations of these diseases have been explored through international clinical databases such as EUROFEVER project. However, clinical features of genetic disorders could be affected by countries and races of the patients. Actually, patients with Familial M...

Database of Wards for Patients with Muscular Dystrophy in Japan

Twenty-seven hospitals in Japan specialize in treatment of muscular dystrophy patients, including inpatient care, of which 26 belong to the National Hospital Organization, and the other is the National Center of Neurology and Psychiatry. Since 1999, Japanese muscular dystrophy research groups investigating nervous and mental disorder have been developing a database of cases treated at these 27 ...

Use of the Physiotherapy Evidence Database (PEDro) in Japan.

BACKGROUND The Physiotherapy Evidence Database (PEDro) may help users to overcome some obstacles to evidence-based physiotherapy. Understanding the extent to which Japanese physiotherapists access research evidence via the PEDro website may suggest strategies to enhance evidence-based physiotherapy in Japan. OBJECTIVES To quantify usage of PEDro in Japan, to compare this to usage in other cou...

ADAMTS13 activity and genetic mutations in Japan.

Thrombotic thrombocytopenic purpura (TTP), a life threatening disease, can be induced by congenital or acquired deficiency of plasma metalloprotease ADAMTS13. Since the publication of the first genetic analysis in patients with congenital ADAMTS13 deficiency in 2001, more than 100 genetic defects in the ADAMTS13 gene have been reported worldwide. Genetic analysis in patients with ADAMTS13 defic...